Surya Pharmaceutical galloped 12.60% to Rs 121.55 at 13:39 IST on BSE after the firm reported 56.5% rise in net profit in Q4 March 2008 over Q4 March 2007.
The stock hit a high of Rs 129.50 and a low of Rs 115 so far during the day. The stock had a 52-week high of Rs 151 on
The small-cap drug maker has an equity capital of Rs 14.47 crore. Face value per share is Rs 10.
The current price of Rs 121.55 discounts its Q4 March 2008 annualised EPS of Rs 36.36, by a PE multiple of 3.34.
The net profit of Surya Pharmaceutical rose 56.5% to Rs 12.79 crore on 90.6% rise in sales to Rs 156.48 crore in Q4 March 2008 over Q4 March 2007.
Surya Pharmaceutical produces semi-synthetic penicillin based products, first generation cephalosporins, anti histamines, drug intermediaries and formulations. The company is predominantly a bulk drug or Active Pharmaceutical Ingredient (API) manufacturer.
No comments:
Post a Comment